1. Home
  2. MATH vs ASRT Comparison

MATH vs ASRT Comparison

Compare MATH & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • ASRT
  • Stock Information
  • Founded
  • MATH 2015
  • ASRT 1995
  • Country
  • MATH Hong Kong
  • ASRT United States
  • Employees
  • MATH N/A
  • ASRT N/A
  • Industry
  • MATH Finance/Investors Services
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATH Finance
  • ASRT Health Care
  • Exchange
  • MATH Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • MATH 60.8M
  • ASRT 65.7M
  • IPO Year
  • MATH N/A
  • ASRT 1997
  • Fundamental
  • Price
  • MATH $1.60
  • ASRT $0.61
  • Analyst Decision
  • MATH
  • ASRT Strong Buy
  • Analyst Count
  • MATH 0
  • ASRT 3
  • Target Price
  • MATH N/A
  • ASRT $3.08
  • AVG Volume (30 Days)
  • MATH 49.3K
  • ASRT 480.8K
  • Earning Date
  • MATH 10-31-2024
  • ASRT 05-05-2025
  • Dividend Yield
  • MATH N/A
  • ASRT N/A
  • EPS Growth
  • MATH N/A
  • ASRT N/A
  • EPS
  • MATH 0.17
  • ASRT N/A
  • Revenue
  • MATH $31,399,049.00
  • ASRT $124,961,000.00
  • Revenue This Year
  • MATH N/A
  • ASRT N/A
  • Revenue Next Year
  • MATH N/A
  • ASRT $11.20
  • P/E Ratio
  • MATH $9.59
  • ASRT N/A
  • Revenue Growth
  • MATH 291.58
  • ASRT N/A
  • 52 Week Low
  • MATH $0.80
  • ASRT $0.51
  • 52 Week High
  • MATH $2.78
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • MATH 45.92
  • ASRT 39.17
  • Support Level
  • MATH $1.47
  • ASRT $0.58
  • Resistance Level
  • MATH $1.70
  • ASRT $0.80
  • Average True Range (ATR)
  • MATH 0.16
  • ASRT 0.05
  • MACD
  • MATH -0.01
  • ASRT 0.00
  • Stochastic Oscillator
  • MATH 47.84
  • ASRT 34.48

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: